Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3,...

Keywords

MedicineHazard ratioClinical endpointSurgeryRandomized controlled trialLung cancerClinical trialAdverse effectPopulationIntention-to-treat analysisInternal medicineConfidence interval

Affiliated Institutions

Related Publications

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Masatoshi Kudo , Richard S. Finn , Shukui Qin +19 more

2018 The Lancet 5118 citations

UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer

David Baldwin , Stephen W. Duffy , Nicholas Wald +3 more

The UK Lung Screen (UKLS) is a randomised controlled trial of the use of low-dose multidetector CT for lung cancer screening. It completed the Health Technology Appraisal (HTA)-...

2011 Thorax 226 citations

Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke

François Gueyffier , Jean‐Pierre Boissel , Florent Boutitie +10 more

Background and Purpose Drug treatment of high blood pressure has been shown to reduce the associated cardiovascular risk. Stroke represents the type of event more strongly linke...

1997 Stroke 247 citations

National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000

Patricia J. Eifel , Jan Axelson , Janitha Costa +11 more

The panel concludes that decisions regarding adjuvant hormonal therapy should be based on the presence of hormone receptor protein in tumor tissues. Adjuvant hormonal therapy sh...

2001 JNCI Journal of the National Cancer I... 894 citations

Publication Info

Year: 2022
Type: article
Volume: 399
Issue: 10335
Pages: 1607-1617
Citations: 1432
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1432

OpenAlex

Cite This

APA Style

                            
                                
                                    Hisashi Saji, 
                                
                                    Morihito Okada, 
                                
                                    Masahiro Tsuboi
                                
                                et al.
                            
                            (2022). 
                            Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. 
                            The Lancet
                            , 399
                            (10335)
                            , 1607-1617.
                            https://doi.org/10.1016/s0140-6736(21)02333-3
                        

Identifiers

DOI: 10.1016/s0140-6736(21)02333-3